If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

The Food and Drug Administration on Tuesday approved Sanofi and Regeneron Pharmaceutical’s drug Dupixent as a treatment for moderate to severe eczema. Here are four things to know. 1. Dupixent, which ...

Nemolizumab is delivered via subcutaneous injection and was approved earlier this year for treating prurigo nodularis in adults. Two identical phase III trials -- ARCADIA 1 and ARCADIA 2-- supported ...

Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after ...

The newly FDA-approved treatment Anzupgo (delgocitinib) could offer steroid-free relief for people living with intensely dry, itchy, painful skin. Anzupgo (delgocitinib) is the first and only topical ...

Amgen (AMGN) stock in focus as the company and Kyowa Kirin (KYKOF) report Phase 3 data showing their atopic dermatitis drug, ...

NEA AWARDS 9 NEW GRANTS FOR ECZEMA RESEARCH TO NEW AND LONGSTANDING INVESTIGATORS PR Newswire NOVATO, Calif., Feb. 27, 2025 New research will explore key aspects of eczema from the science behind itch ...

Summer brings long days, outdoor fun, and plenty of sunshine—but for people living with chronic skin conditions like eczema, ...

For those in need of skincare products designed to deal with eczema or eczema-related symptoms, the search for possible solutions can quickly turn into a nightmare. The process features plenty of ...

JOHNSON CITY, Tenn., March 27, 2025 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown"), a fully integrated global skincare company, is excited to announce the launch of Sarna ® Eczema Relief Skin ...